FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to application of sibutramine metabolite as a new agent used for treatment of deficiency in attention or with combination with hyperactivity.
EFFECT: valuable medicinal properties of compositions.
9 cl, 3 tbl, 10 sch, 15 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS CONTAINING MONOAMINE REUPTAKE INHIBITOR AND METHODS OF THEIR APPLICATION | 2004 |
|
RU2358719C2 |
METHODS FOR ADMINISTRATION OF 3-(4-AMINO-1-OXO-1,3-DIHYDROISOINDOLE-2-YL)PIPERIDINE-2,6-DIONE IN CERTAIN TYPES OF LEUKEMIA | 2006 |
|
RU2406501C2 |
TETRAHYDROPYRANYL AMINO-PYRROLOPYRIMIDINONE AND METHODS OF ITS USE | 2020 |
|
RU2747991C1 |
TETRAHYDROPYRANYL AMINO-PYRROLOPYRIMIDINONE AND METHODS FOR USE THEREOF | 2015 |
|
RU2715421C2 |
METHODS AND COMPOSITIONS USING IMMUNOMODULATORY COMPOUNDS FOR TREATMENT AND MAINTENANCE OF CANCER AND OTHER DISEASES | 2004 |
|
RU2348407C2 |
USE OF 3-(4-AMINO-1-OXO-1, 3-DIHYDROISOINDOL-2-YL)PIPERIDINE-2,6-DIONE FOR TREATING MANTLE CELL LYMPHOMAS | 2007 |
|
RU2446804C2 |
METHOD OF TREATMENT OF ENURESIS USING (S)-OXYBUTYNIN AND (S)-DESETHYLOXYBYTININ | 1997 |
|
RU2195276C2 |
USE OF TRYPTOPHAN METABOLITES FOR THE TREATMENT OF MUSCULAR ATROPHY | 2017 |
|
RU2806346C2 |
OBTAINING AND USING PHENYLCYCLOBUTYLAMIDE DERIVATIVES AND STEREOISOMERS THEREOF | 2009 |
|
RU2479572C2 |
SELECTIVE ANDROGEN RECEPTOR MODULATORS | 2007 |
|
RU2435756C2 |
Authors
Dates
2004-10-20—Published
1999-08-23—Filed